Product Profile of Ofloxacin Ip And Ornidazole Ip Based Antibiotic
Ofloxacin IP and Ornidazole IP Based Antibiotic is a synthetic chemotherapeutic antibiotic of the fluoroquinolone medicine category. Ofloxacin IP Based Antibiotic is ideal for curing acute bacterial exacerbations of chronic bronchitis, acute pelvic inflammatory disease, uncomplicated skin and skin structure infections and non-gonococcal urethritis and cervicitis. Ornidazole IP Based Antibiotic can effectively cure anaerobic infections in both pre and post operative stages, amoebic dysentery, Amoebic liver abscess, bacterial vaginosis and hepatic and intestinal amoebiasis. Ofloxacin IP and Ornidazole IP Based Antibiotic can be availed in different packaging options to cater to specific requirement.
Applications of Ofloxacin IP and Ornidazole IP Based Antibiotic:
- Anaerobic infections both pre & post operatively [Ornidazole]
- Amoebic dysentery [Ornidazole]
- Amoebic liver abscess[Ornidazole]
- Bacterial vaginosis[Ornidazole]
- Hepatic and intestinal amoebiasis[Ornidazole]
- Some other protozoan infection including Giardiasis and Trichomoniasis[Ornidazole]
- Acute bacterial exacerbations of chronic bronchitis [Ofloxacin]
- Acute pelvic inflammatory disease [Ofloxacin]
- Uncomplicated skin and skin structure infections [Ofloxacin]
- Nongonococcal urethritis and cervicitis [Ofloxacin]
- Community-acquired pneumonia [Ofloxacin]
- Mixed Infections of the urethra and cervix [Ofloxacin]
- Uncomplicated cystitis [Ofloxacin]
- Acute, uncomplicated urethral and cervical gonorrhoea [Ofloxacin]
- Complicated urinary tract infections [Ofloxacin]